Turps, I am still a big beleiver however One of the major frustrations with POH is they have had a huge cache of weapons at their disposal. eg functional foods, cosmetics(they have tried), OTC, animal health(IAH kicking goals)
I understand they have focused on the patches. Fair enough. But there are so many possibilities with the TPM tech that have not been exploited. Perhaps the key with animal health has been it being a seperate company focused on their market. I am perhaps being a little unfair as they did get deals that didnt eventuate with rod cutler and prophase. But deals have been very thin on the ground for such a long period.
Why has this been the case? I don't beleive it is published papers(so shhh Playez)
POH can prove 5-10times better with so many compounds. These results can be verified quickly and easily by prospects. So why no or almost no deals? We can see what IAH has done.(albeit shareholders don't know terms) So surely other companies could do similar??
Surely deals where POH get something of something is better than no deals where POH get a huge % of nothing.
What is holding things back on these fronts? It has been years and years.
.
POH Price at posting:
9.3¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)